Advances in Cancer Immunotherapy

Cancer immunotherapy with anti-PD-1 antibodies has fundamentally changed the way we think about cancer treatment. As Honjo Tasuku traces the arc of his research from a serendipitous discovery to the development of a revolutionary therapy, he engages in a wide ranging discussion of the marvels of biological phenomena, the thrill of life science’s explorations of the unknown, the nature of life itself, and the future of Japanese healthcare. In the preface to the English edition, Dr. Honjo shares his thoughts about how we should grapple with life in the time of COVID-19 and offers a message to the next generation. Included at the end of the book is the transcript of Dr. Honjo’s Nobel Prize banquet speech.

HONJO Tasuku
Dr. Honjo Tasuku was born in Kyoto in 1942. After graduating from the Faculty of Medicine, Kyoto University, and completing his doctorate at the university’s Graduate School of Medicine, he went on to positions such as fellow at the Carnegie Institution of Washington; visiting fellow at the National Institutes of Health in the United States; assistant professor of the Faculty of Medicine, University of Tokyo; professor of the Faculty of Medicine at both Osaka University and Kyoto University. He currently serves as deputy director-general and distinguished professor of the Kyoto University Institute for Advanced Study as well as director of the Center for Cancer Immunotherapy and Immunobiology at Kyoto University Graduate School of Medicine. Dr. Honjo is a winner of the 2018 Nobel Prize in Physiology or Medicine.

Selected works: Kofukukan ni kansuru Seibutsugakuteki Zuiso [Biological Reflections on Happiness]. Shodensha, 2020.

Genomu ga Kataru Seimeizo: Gendaijin no tame no Saishin Seimei Kagaku Nyumon [The Image of Life as Told by the Genome: A New Introduction to Life Science for Today]. Kodansha, 2013.

Men’eki to Ketsueki no Kagaku (Iwanami Koza Gendai Igaku no Kiso 8) [The Science of Immunity and Blood, volume 8. Iwanami Courses: Principles of Current Medicine], joint editor. Iwanami Shoten, 1999.

Seimeitai no Mamorikata (Iwanami Koza Bunshi Seibutsugaku 11) [How Organisms Defend Themselves, volume 11. Iwanami Courses: Molecular Biology], editor. Iwanami Shoten, 1991.

*information as of time of publication

Japan Library series
Science

Publisher:
Japan Publishing Industry Foundation for Culture

Hardcover
¥2,300 + tax
ISBN 9784866581767
210 mm x 148 mm / 168 pp. / March 2021

eBook
ISBN 9784866581880 (ePub)
ISBN 9784866581996 (PDF)

CONTENTS
Preface to the English Edition
Introduction
1. The Marvel of Immunity
2. Curing Cancer with Anti-PD-1 Antibodies
3. What Is Life?
4. Biomedical Science Research in Society
5. Thinking about the Future of Japanese Healthcare
References
Nobel Prize in Physiology or Medicine Banquet Speech
Epilogue
Index

PD-1抗体を用いたがん免疫療法は、がん治療の考え方を根本的に変えた。本書では、偶然の発見を革新的治療法の開発にまで導いた著者の歩みを辿る。英文版序文ではコロナ禍の生活についてと次世代へのメッセージを新規掲載。

本庶 佑
1942年生まれ。京都大学医学部卒業、同大学院医学研究科博士課程修了、カーネギー研究所招聘研究員、アメリカ国立衛生研究所客員研究員、東京大学医学部助手、大阪大学医学部教授、京都大学医学部教授などをへて現在、京都大学高等研究院副院長・特別教授。専攻は分子免疫学。2018年ノーベル生理学医学賞受賞。

＊著者略歴は書籍刊行時のものを表示しています。